Enlivex Therapeutics Statistics

Total Valuation

ENLV has a market cap or net worth of $22.32 million. The enterprise value is $1.77 million.

Market Cap	22.32M
Enterprise Value	1.77M

Important Dates

The next estimated earnings date is Friday, June 13, 2025, after market close.

Earnings Date	Jun 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ENLV has 23.85 million shares outstanding. The number of shares has increased by 16.88% in one year.

Current Share Class	23.85M
Shares Outstanding	23.85M
Shares Change (YoY)	+16.88%
Shares Change (QoQ)	+5.64%
Owned by Insiders (%)	4.61%
Owned by Institutions (%)	7.35%
Float	20.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.08
P/TBV Ratio	1.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.20

Current Ratio	7.20
Quick Ratio	6.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.35% and return on invested capital (ROIC) is -38.97%.

Return on Equity (ROE)	-60.35%
Return on Assets (ROA)	-34.24%
Return on Invested Capital (ROIC)	-38.97%
Return on Capital Employed (ROCE)	-72.23%
Revenue Per Employee	n/a
Profits Per Employee	-$201,775
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.55% in the last 52 weeks. The beta is 0.76, so ENLV's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-28.55%
50-Day Moving Average	0.98
200-Day Moving Average	1.18
Relative Strength Index (RSI)	40.11
Average Volume (20 Days)	54,118

Short Selling Information

Short Interest	121,442
Short Previous Month	136,863
Short % of Shares Out	0.53%
Short % of Float	n/a
Short Ratio (days to cover)	2.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.09M
Pretax Income	-25.99M
Net Income	-14.33M
EBITDA	-14.64M
EBIT	-15.09M
Earnings Per Share (EPS)	-$0.66

Full Income Statement

Balance Sheet

The company has $20.55 million in cash and n/a in debt, giving a net cash position of $20.55 million or $0.86 per share.

Cash & Cash Equivalents	20.55M
Total Debt	n/a
Net Cash	20.55M
Net Cash Per Share	$0.86
Equity (Book Value)	20.63M
Book Value Per Share	0.87
Working Capital	19.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.12 million and capital expenditures -$92,000, giving a free cash flow of -$13.21 million.

Operating Cash Flow	-13.12M
Capital Expenditures	-92,000
Free Cash Flow	-13.21M
FCF Per Share	-$0.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.88%
Shareholder Yield	-16.88%
Earnings Yield	-64.17%
FCF Yield	-59.19%

Analyst Forecast

The average price target for ENLV is $10.00, which is 968.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	968.38%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1